AzTrials
AzTrials

Respiratory FailureREACHNCT04146753

Identifying and Understanding Risk Factors for Instability and Adverse Events Associated With Chest Physiotherapy in Ventilated Children

An observational study of Respiratory Failure, run by Great Ormond Street Hospital for Children NHS Foundation Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Paediatric intensive care units support the complex medical needs of children with life threatening conditions. There are 20000 admissions annually within the United Kingdom and 65% require life support through a breathing machine. Chest physiotherapy is considered part of routine care for these patients. Read more about this study

Who is it for?
Ages 0 to 4 years
Conditions the study is for
Respiratory Failure
How many people
556 participants
Where
1 siteUnited Kingdom
Study dates
29 Jul 2020to 22 Nov 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 4 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children across three intensive care units at a tertiary childrens hospital

Who may be able to join

  • Intubated and mechanically ventilated
  • Receiving chest physiotherapy
  • 0-4 years of age
  • First four days of mechanical ventilation

Who cannot join

  • Newborn premature babies (currently <36 weeks gestation)
  • Patients requiring mechanical circulatory support
  • Patients not for escalation of care or not receiving active treatment

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Great Ormond Street Hospital

    London

Other trials in United Kingdom

About this study

Paediatric intensive care units support the complex medical needs of children with life threatening conditions. There are 20000 admissions annually within the United Kingdom and 65% require life support through a breathing machine. Chest physiotherapy is considered part of routine care for these patients. There is a small amount of evidence providing support for the effectiveness of chest physiotherapy however it has been associated with instability and adverse events. At present the risks and benefits of chest physiotherapy in ventilated children are unknown. It is important to identify which patients are likely to benefit most and in which situations chest physiotherapy may present a significant risk.

Aim: To identify and understand the risk factors for instability and harmful events which may occur due to chest physiotherapy in children on intensive care.

Read more

Design/Methods

Work Package 1

Phase 1 - An anonymous, electronic survey will be sent to all UK physiotherapists who work in paediatric critical care. Information will be collected about physiotherapy practice, referrals, and risk factors assessed and monitored.

Phase 2 - Interviews with 18-27 physiotherapists will take place. The findings from phase 1 will guide the questions. Phase 2 will provide a more in-depth understanding about physiotherapy decision making and management of risks.

Work Package 2

This part of the study will quantitatively assess the effects of chest physiotherapy and identify risk factors for instability. Routinely collected data from the three intensive care units at Great Ormond Street Hospital will be used. No contact with patients/families will be required, and no change to care will occur. Data from approximately 1000 patients will be collected over one year. Health related measures (e.g. oxygen levels) will be recorded before and after chest physiotherapy.

Read the detailed description

Research Questions

  1. What is current chest physiotherapy practice within UK paediatric intensive care units?
  2. How do physiotherapists make decisions regarding provision of chest physiotherapy in UK paediatric intensive care units and what other factors influence this decision making?
  3. What do physiotherapists perceive to be risk factors for physiological instability and adverse events and how do they manage these?
  4. What is the prevalence of physiological instability and adverse events associated with chest physiotherapy in ventilated children?
  5. What are the risk factors/characteristics of children who display instability and/or adverse events associated with chest physiotherapy?
  6. What is the long term impact on the child of instability and adverse events associated with chest physiotherapy?

WORK PACKAGE 1

Phase 1 A descriptive, cross sectional study investigating current chest physiotherapy practice in paediatric intensive care units.

Sample The subject group is physiotherapists working within the 28 NHS PICUs in the UK. Using information from a local benchmarking study which investigated physiotherapy staffing levels on seven UK PICUs, a total of 33 physiotherapy staff was reported, providing an average of four per site. Extrapolating this for the 28 national centres gives an approximate population size of 112 physiotherapists.

Method An electronic survey, created in Smart-survey will be used. The first page of the questionnaire will include a covering statement and a link to the more comprehensive participant information sheet. The survey includes dichotomous and multiple choice closed questions, and open questions where more detail is required. It will be self-administered and anonymous.

Key topics covered include:

  • Chest physiotherapy techniques used
  • Chest physiotherapy referral criteria
  • Decision to treat/not treat processes
  • Risk factors monitored
  • Demographic information The survey will be open for eight weeks and a reminder email will be sent after four weeks. Consent will be implied if the survey is completed and returned.

Data Analysis The anonymous data will be imported into Excel and descriptive statistics will be used including frequency distributions, statistics of central tendency, and dispersion. Qualitative data from the open questions will be thematically analysed, as described by Braun and Clarke (2006).

Phase 2 A qualitative study to explore and understand the decision making processes that guide delivery of chest physiotherapy, including the perceived risk factors for physiological instability and adverse events, and risk management strategies.

Sample Nine paediatric critical care units have been pre-selected, these are representative of all 28 UK NHS PICUs. Up to three physiotherapists will be purposively sampled from each centre to ensure a heterogeneous sample in terms of agenda for change banding and years of experience. This strategy will generate a sample size of 18-27 and ensure saturation of themes.

Method Semi-structured interviews will be conducted. Eligible participants will be provided with appropriate study information and all participants asked to give written consent prior to taking part. The interviews will take place at a time and location convenient to the participant, outside of their contracted working hours. The interviews will last between 30-60 minutes. Where possible the interviews will be face to face, however Skype/telephone interviews will also be offered. A topic guide for the interviews will be developed using the data from phase 1, existing literature, and advice from the steering group. The topic guide will be piloted in the first three interviews. The pilot data will be included in the data set unless significant revisions to the topic guide are required. The interviews will be audio recorded, with permission, and transcribed verbatim. Field notes will be taken to provide context and information on non-verbal cues.

Data Analysis Thematic analysis will be used to analyse the interview transcripts, to identify, organise and report themes within the data. The themes will be presented logically and meaningfully, evidenced and illustrated with quotes as appropriate. A visual display of the findings will also be developed.

WORK PACKAGE 2 An observational (case-note review) study to assess the variability and prevalence of physiological instability and adverse events associated with chest physiotherapy, and identify risk factors that predict instability.

Sample The sampling frame will consist of patients on the three paediatric critical care units at a tertiary children's hospital (neonatal, general paediatric, cardiac).

Subject Recruitment Patients who meet the inclusion criteria will be identified from physiotherapy records on a weekly basis by the chief investigator.

Data Collection This study will involve the collection of four categories of variables: primary and secondary outcomes, risk factors/demographics, and general PICU outcomes. These are routinely monitored and recorded for all patients on the PICUs. They are retrieved from high resolution monitor data (T3) and electronic patient records (EPR). A workspace within the digital platform Aridhia will be designed collaboratively with the GOSH Digital Research, Informatics and Virtual Environments (DRIVE) team. This will provide a comprehensive and secure database to collate, store and analyse the data. The DRIVE team will downloaded the de-identified data into the workspace.

Sample Size and Planned Recruitment Rate The use of digital methods allows a larger sample than in previous experimental and retrospective studies. Retrospective data will be collected over a 12 month period. An audit of chest physiotherapy across the three PICUs was completed over one week. Twenty two patients, accounting for 77 CPT events, were identified who would meet the study inclusion criteria. Scaling this up, data collection over a 12 month period would provide an approximate sample of 1144 patients and 4000 CPT treatments. Completing the data collection over a full year will avoid the impact of seasonal bias on the sample.

Data Analysis The analysis will be completed using the R Project for Statistical Computing. Multilevel analysis will be used to investigate change in the physiological variables and allow risk modelling.

Data Synthesis The findings of both work packages will be synthesised to determine similarities and disparities between the perceived risks of physiological instability and adverse events associated with CPT and those demonstrated by the objective data. Side by side comparison for merged data analysis will be used in a summary table and through visual data representation. This will clarify the new knowledge created and areas for service improvement.

Keywords
Chest physiotherapy, Paediatric intensive care unit, Physiological instability, Adverse events
Medical subject headings
Respiratory Insufficiency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygenation

    Work package 2 - Arterial oxygen saturations (SpO2), measured non-invasively by a finger pulse oximeter.

    Measured: Change in baseline Sp02 for 30 minutes before chest physiotherapy and 30 minutes after

Secondary outcomes (3)
  1. Heart rate

    Work package 2 - Heart rate (HR) - measured by Electrocardiography.

    Measured: Change in baseline HR for 30 minutes before chest physiotherapy and 30 minutes

  2. Mean blood pressure

    Work package 2 - Mean arterial blood pressure (MBP) - measured invasively by an arterial line or non-invasively by a blood pressure cuff.

    Measured: Change in baseline HR and MBP for 30 minutes before chest physiotherapy and 30 minutes

  3. Presence of Adverse Events

    Work package 2

    • Presence of cardiac arrhythmia (yes/no)
    • Unplanned extubation (yes/no)
    • Cardiorespiratory arrest (yes/no)
    • Loss of venous access (yes/no)

    Measured: 30 minutes after chest physiotherapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2019
  2. Study start29 Jul 2020
  3. Primary completion22 Nov 2021
  4. Study completion22 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
556 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04146753
Sponsor's protocol ID
18BA19
Acronym
REACH
Status last verified
Jan 2022
First submitted
9 Oct 2019
Last updated
10 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Failure, run by Great Ormond Street Hospital for Children NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygenation (time frame: Change in baseline Sp02 for 30 minutes before chest physiotherapy and 30 minutes after). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in